Has Margaret Riley received payments from drug or device companies?

Yes. Drug and device makers reported $6,088 in general payments to Margaret Riley across 176 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Margaret Riley did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Margaret Riley come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Margaret Riley

Psychiatry · Roxbury, MANPI 1134284656

Payments from drug & device makers

$6,088in general payments, 2019–2025

Across 176 payments — averaging $34.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$1K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$960
Teva Pharmaceuticals USA, Inc.$705
Neurocrine Biosciences, Inc.$583
Johnson & Johnson$543
E.r. Squibb & Sons, L.L.C.$501
plus $1K from 7 others

What the payments were for

Food & beverage$5,75495%
Education$3345%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	26	$1,349
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	28	$960
Teva Pharmaceuticals USA, Inc.	30	$705
Neurocrine Biosciences, Inc.	21	$583
Johnson & Johnson	19	$543
E.r. Squibb & Sons, L.L.C.	8	$501
Sunovion Pharmaceuticals Inc.	16	$462
W. L. Gore & Associates, Inc.	3	$390
Otsuka America Pharmaceutical, Inc.	6	$204
Vanda Pharmaceuticals Inc.	5	$151
Lundbeck LLC	7	$132
Ironshore Pharmaceuticals Inc.	4	$63
Avanir Pharmaceuticals, Inc.	3	$45

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,088 in reported general payments places this provider in the 90th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Abilify MaintenaAripiprazole	27	$78,584
Risperdal ConstaRisperidone Microspheres	31	$39,302
Lurasidone Hcl	74	$30,069
Risperidone ErRisperidone Microspheres	22	$13,449
Clonazepam	748	$7,601
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	252	$6,995
TrintellixVortioxetine Hydrobromide	12	$6,839
Aripiprazole	104	$6,573
Clozapine	74	$4,917
Quetiapine Fumarate	248	$4,719
Gabapentin	307	$4,391
Divalproex Sodium ErDivalproex Sodium	111	$4,278
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	111	$3,797
Risperidone	286	$3,564
Olanzapine	243	$3,297

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena	$204	$78,58427 claims
Johnson & JohnsonRisperdal Consta	$543	$39,30231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Roxbury

Lee CohenBoston$7M
Dyanna DomiliciBoston$5.8M
Arkadiy StolyarBelmont$3.3M
Maurizio FavaBoston$2.8M
Marc ShayAmesbury$1.7M
Martha StarkNewton$1.6M
Hadine JoffeBoston$1.5M
Malini NairWinchester$1M
Xiaoduo FanWorcester$950K
Anthony RothschildWorcester$838K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →